It is a pharma private limited company based in Kolkata, West Bengal, India, established in 2021.
2021 | Kolkata, West Bengal, India | ActiveFeminova Pharmaceuticals Private Limited, a active private limited company, was established on 01 April 2021 in Kolkata, West Bengal, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U85100WB2021PTC244307. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.40 M.
Its leadership includes Aurobinda Banerjee (Director), Sabir Hossain (Director), Khondaker Nurul Islam (Additional Director). Past directors included Jyotirmoy Roy Karmakar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 191 Debinibash Road, Kolkata, West Bengal, 700074.
U85100WB2021PTC244307
244307
01 April 2021
₹1.00 M
₹0.40 M
Roc Kolkata
Unlisted
Active
Explore comprehensive insights into Feminova Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aurobinda Banerjee | Director | 01 Apr 2021 | Current |
| Sabir Hossain | Director | 01 Apr 2021 | Current |
| Khondaker Nurul Islam | Additional Director | 27 Dec 2022 | Current |
| Abhijit Basu | Director | 01 Apr 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 02 Aug 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Feminova Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1645% decrease in profit. The company's net worth observed a substantial decline by a decrease of 91.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Feminova Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Feminova Pharmaceuticals has a workforce of 0 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Feminova Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Feminova Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Feminova Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Feminova Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kolkata. was documented.
Progress on Khondaker Nurul Islam was appointed as a Additional Director was appointed as a Additional Director on 27 Dec 2022 & has been associated with this company since 2 years 11 months . was documented.
Aurobinda Banerjee was appointed as a Director was appointed as a Director on 01 Apr 2021 & has been associated with this company since 4 years 8 months . was recorded as a recent event.
Sabir Hossain was appointed as a Director was appointed as a Director on 01 Apr 2021 & has been associated with this company since 4 years 8 months . was recorded as a recent event.
Progress on Abhijit Basu was appointed as a Director was appointed as a Director on 01 Apr 2021 & has been associated with this company since 4 years 8 months . was documented.
The CIN of Feminova Pharmaceuticals Private Limited is U85100WB2021PTC244307.
Feminova Pharmaceuticals Private Limited is headquartered at 191 Debinibash Road, Kolkata, West Bengal, 700074.
Feminova Pharmaceuticals Private Limited was incorporated on 01 April 2021.
The current directors of Feminova Pharmaceuticals Private Limited are
The primary industry of Feminova Pharmaceuticals Private Limited is Pharma.
Feminova Pharmaceuticals Private Limited is unlisted.
The authorized capital of Feminova Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.40 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX